Association between polymorphisms of the angiotensin-converting enzyme and angiotensinogen genes and allergic rhinitis in a Korean population

Annals of Otology, Rhinology and Laryngology

Volumn 113, Issue 4, 2004, Pages 297-302

  Kim, Jeong Joong ^a,b   Kim, Hyun Ju ^a,b   Lee, Il Kwon ^a,c   Chung, Hun Taeg ^a,b   Lee, Jae Hoon ^a,b  

^a Wonkwang Univ School of Medicine ^*

^b Wonkwang University School of Medicine   (South Korea)

^c Chonnam National University Medical School   (South Korea)

Author keywords

Allergic rhinitis; Angiotensin converting enzyme; Angiotensinogen; Korean population; Polymorphism

Indexed keywords

ANGIOTENSINOGEN; BRADYKININ; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; INTERLEUKIN 1; NEUROKININ A; SUBSTANCE P;

ADULT; ALLELE; ALLERGIC RHINITIS; ARTICLE; ATOPY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; ENZYME INACTIVATION; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFLAMMATION; KOREA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 16544390895     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940411300408     Document Type: Article

References (23)

1. Sadanaga Y, Uno M, Kitao Y, Ishikawa T. Investigation of the genetic regulation in allergic rhinitis. Auris Nasus Larynx 1990;17:23-32.
2. Barnes PJ. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma. J Allergy Clin Immunol 1989:83:1013-26.
3. Wiemer G, Scholkens BA, Becker RH, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 1991;18:558-63.
4. Skeggs LTD Jr, Kahn JR, Shumway NP. The preparation and function of the hypertensin-converting enzyme. J Exp Med 1956;103:295-9.
5. Cambien F, Alhenc-Gelas F, Herbeth B, et al. Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study. Am J Genet 1988;43:774-80.
6. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
7. Costerousse O, Allergrini J, Lopez M, Alhenc-Gelas F. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993;290:33-40.
8. Ron D, Brasier AR, Wright KA, Tate JE, Habener JF. An inducible 50-kilodalton NFκB-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene. Mol Cell Biol 1990;10:1023-32.
9. Brasier AR, Ron D, Tate JE, Habener JF. A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1α induced, NFκB mediated trans-activation of angiotensinogen gene acute-phase response element. EMBO J 1990;9:3933-44.
10. Wintroub BU, Klickstein LB, Dzau VJ, Watt KWK. Granulocyte-angiotensin system. Identification of angiotensinogen as the plasma protein substrate of leukocyte cathepsin G. Biochemistry 1984;23:227-32.
11. Robertson AL, Khairallah PA. Effects of angiotensin II and some analogues on vascular permeability in the rabbit. Circ Res 1972;31:923-31.
12. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-80.
13. Holla L, Vasku A, Znojil V, Siskova L, Vacha J. Association of 3 gene polymorphisms with atopic diseases. J Allergy Clin Immunol 1999;103:702-8.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
15. Gotoh M. Role of angiotensin-converting enzyme on bradykinin nasal provocation: comparison of normal volunteers and allergic subjects [in Japanese]. Nippon Jibiinkoka Gakkai Kaiho 1999;102:218-25.
16. Tomita H, Sato S, Matsuda R, et al. Genetic polymorphism of the angiotensin-converting enzyme (ACE) in asthmatic patients. Respir Med 1998;92:1305-10.
17. Schindler R, Dinarello CA, Koch KM. Angiotensin-converting-enzyme inhibitors suppress synthesis of tumor necrosis factor and interleukin 1 by human peripheral blood mononuclear cells. Cytokine 1995;7:526-33.
18. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995:332:706-11.
19. Benessiano J, Crestani B, Mestari F, et al. High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma. J Allergy Clin Immunol 1997;99:53-7.
20. Furuya K, Yamaguchi E, Hirabayashi T, et al. Angiotensin-converting enzyme gene polymorphism and susceptibility to cough. Lancet 1994;343:354.
21. Tomita H, Ina Y, Sugiura Y, et al. Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis. Am J Respir Crit Care Med 1997;156:255-9.
22. Katsuya T, Koike G, Yee TW, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995;345:1600-3.
23. Winkelmann BR, Russ AP, Nauck M, et al. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J 1999;137:698-705.